Health Care & Life Sciences » Medical Equipment & Supplies | Oculus Innovative Sciences Inc.

Oculus Innovative Sciences Inc. | Balance Sheet

Fiscal year is April-March. All values USD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
5,480.00
6,136.00
7,469.00
17,461.00
10,066.00
Total Accounts Receivable
2,327.00
1,517.00
1,508.00
2,108.00
1,537.00
Inventories
1,088.00
1,402.00
1,595.00
2,221.00
2,865.00
Other Current Assets
647.00
592.00
2,316.00
616.00
1,547.00
Total Current Assets
9,542.00
9,647.00
12,888.00
22,406.00
16,015.00
Net Property, Plant & Equipment
971.00
795.00
850.00
1,239.00
1,136.00
Total Investments and Advances
10,150.00
4,538.00
-
-
-
Other Assets
128.00
68.00
65.00
1,814.00
2,055.00
Total Assets
20,791.00
15,048.00
13,803.00
25,459.00
19,206.00
ST Debt & Current Portion LT Debt
143.00
87.00
114.00
197.00
377.00
Accounts Payable
736.00
932.00
1,337.00
1,255.00
1,272.00
Income Tax Payable
-
-
-
13.00
-
Other Current Liabilities
6,693.00
1,562.00
2,100.00
1,823.00
1,612.00
Total Current Liabilities
7,572.00
2,581.00
3,551.00
3,288.00
3,261.00
Long-Term Debt
4.00
-
-
213.00
176.00
Other Liabilities
1,152.00
413.00
112.00
527.00
443.00
Total Liabilities
8,728.00
2,994.00
3,663.00
4,028.00
3,880.00
Common Equity (Total)
12,063.00
12,054.00
10,140.00
21,431.00
15,326.00
Total Shareholders' Equity
12,063.00
12,054.00
10,140.00
21,431.00
15,326.00
Total Equity
12,063.00
12,054.00
10,140.00
21,431.00
15,326.00
Liabilities & Shareholders' Equity
20,791.00
15,048.00
13,803.00
25,459.00
19,206.00

About Oculus Innovative Sciences

View Profile
Address
1129 North McDowell Boulevard
Petaluma California 94954
United States
Employees -
Website http://www.sonomapharma.com
Updated 09/14/2018
Sonoma Pharmaceuticals, Inc. engages in identifying, developing, and commercializing therapies for chronic skin conditions. It offers solutions in dermatology, animal healthcare, and advanced tissue care product areas. Its products target skin diseases including acne, atopic dermatitis, scarring, infections, itch, pain, and harmful inflammatory responses.